Expressed RNAi for lasting treatment or cure

Tacere Therapeutics develops human therapeutics based on RNA interference (RNAi)  and ddRNAi gene-silencing technology from Benitec Biopharma. Using this approach, the drugs we create promise long term treatment or cure with a single dose.

We target human diseases for which there is currently no effective treatment.  Our pipeline includes drugs for Hepatitis C and Age-Related Macular Degeneration.

Tacere Therapeutics is a Benitec Biopharma company.

Our biological drugs target and silence unwanted genes, safely and with lasting effect.

TT-034, our drug to treat Hepatitis C with a single dose, is poised to commence clinical trial.


Tacere Therapeutics Inc, 4900 Hopyard Rd, Suite 100, Pleasanton CA 94588, USAP. +1 925 858 9299           E.

Copyright © Tacere Therapeutics Inc. All rights reserved.                   Home | Contact